ArticleDrug design, development and therapy2017

Reversal of multidrug resistance in human lung cancer cells by delivery of 3-octadecylcarbamoylacrylic acid-cisplatin-based liposomes.

Juan Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.